These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin. Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate. Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589 [No Abstract] [Full Text] [Related]
46. Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. Bray B; Lane DA; Freyssinet JM; Pejler G; Lindahl U Biochem J; 1989 Aug; 262(1):225-32. PubMed ID: 2818566 [TBL] [Abstract][Full Text] [Related]
47. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876 [TBL] [Abstract][Full Text] [Related]
48. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma. Simmons RB; Newton GR; Doctor VM Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997 [TBL] [Abstract][Full Text] [Related]
49. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758 [TBL] [Abstract][Full Text] [Related]
50. Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. Griffith MJ; Noyes CM; Church FC J Biol Chem; 1985 Feb; 260(4):2218-25. PubMed ID: 3838304 [TBL] [Abstract][Full Text] [Related]
51. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II. Hurst RE; Poon MC; Griffith MJ J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430 [TBL] [Abstract][Full Text] [Related]
52. The relative molecular mass dependence of the anti-factor Xa properties of heparin. Ellis V; Scully MF; Kakkar VV Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942 [TBL] [Abstract][Full Text] [Related]
53. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation. Scully MF; Ellis V; Kakkar VV Thromb Res; 1986 Feb; 41(4):489-99. PubMed ID: 2421433 [TBL] [Abstract][Full Text] [Related]
54. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism. Preissner KT; Delvos U; Müller-Berghaus G Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185 [TBL] [Abstract][Full Text] [Related]
55. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration. Collen D; Schetz J; de Cock F; Holmer E; Verstraete M Eur J Clin Invest; 1977 Feb; 7(1):27-35. PubMed ID: 65284 [TBL] [Abstract][Full Text] [Related]
56. Inhibition of urokinase by complex formation with human antithrombin III in absence and presence of heparin. Clemmensen I Thromb Haemost; 1978 Jun; 39(3):616-23. PubMed ID: 705690 [TBL] [Abstract][Full Text] [Related]
57. Plasma inhibitors of the Hageman factor dependent pathways. Schreiber AD Semin Thromb Hemost; 1976 Jul; 3(1):32-51. PubMed ID: 799348 [TBL] [Abstract][Full Text] [Related]
58. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [TBL] [Abstract][Full Text] [Related]
59. Studies on factor XII in porcine plasma: purification and its conversion to activated form by porcine plasma kallikrein. Mashiko H; Kato K; Fujii K; Takahashi H Biochim Biophys Acta; 1996 Sep; 1296(2):198-206. PubMed ID: 8814227 [TBL] [Abstract][Full Text] [Related]
60. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan. Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]